Animal Health Professionals Site

7 January 2015

MSD Animal Health Equine Launches New Support Materials
- Keeping Britain’s Horses Healthy

Milton Keynes, January 07, 2015 – MSD Animal Health’s equine division has launched its new series of materials to support its Keeping Britain’s Horses Healthy Campaign (KBHH). 

These include materials for both yards and veterinary practice reception areas.  The yard materials provide posters giving guidance and advice on prevention of Infectious Respiratory Disease and the steps which should be taken to control a potential outbreak. Both pieces have the ability to be tailor made to an individual yard.  The vet materials include a Vet Reception Pack, aiming to help receptionists educate owners on why they should vaccinate and the benefits of preventive healthcare.

Peter Young, MSD Animal Health Equine Business Manager comments:  “Our first wave of support materials focused very much on equine vets and owners – helping raise awareness of the importance of preventive healthcare and driving owners towards vets for advice.  This phase of materials helps support yard owners and receptionists, aiming to fill some of those communications gaps where advice and guidelines on individual horse’s vaccination requirements and yard protocols can play a vital role in preventing the spread of disease and controlling outbreaks.”  

KBHH is a national campaign to educate horse owners on endemic infectious disease, vaccination, herd immunity and the importance of preventative healthcare.  A wide range of educational materials are available for veterinary surgeries and direct to owners.  A national PR, advertising and social media programme supports the campaign, creating a high level of awareness, together with a dedicated website  The website, aimed at driving owners back to their veterinary practices, includes a vet finder, exclusively for equine practices, and healthcare information. 

For full details of the launch programme and how your practice can get involved with Keeping Britain’s Horses Healthy Campaign talk to your Account manager, call us on 01908 685685 or refer to

About MSD Animal Health

Today's MSD is a global healthcare leader working to help the world be well. MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, NJ, USA., is the global animal health business unit of MSD. Through its commitment to the Science of Healthier Animals™, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit

MSD forward-Looking Statement

This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of MSD’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; MSD’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of MSD’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

MSD undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in MSD’s 2013 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (